Metraipolis › archive › dc_2a5e5ed2e7ea

Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41109919
DOI
10.1038/s41591-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T05:20:29.938Z
SHA-256 of the archived text
a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3
Stable URL of this page
https://metraipolis.com/documento/dc_2a5e5ed2e7ea

How to cite

Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919 — Europe PMC (en), https://europepmc.org/article/MED/41109919 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a5e5ed2e7ea (Metraipolis archive dc_2a5e5ed2e7ea, sha256 a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3)
BibTeX
@misc{dc2a5e5ed2e7ea,
  title = {Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41109919},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a5e5ed2e7ea; sha256 a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41109919. Agents can read the archived copy with the MCP tool read_document.